673
vs
COR
673
COR
Over the past 12 months, China Health Group Ltd has significantly outperformed COR, delivering a return of +259% compared to the COR's +46% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
673
COR
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
China Health Group Ltd
HKEX:673
|
0.65
HKD
|
|||||
|
Cencora Inc
NYSE:COR
|
366.615
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
673, COR
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
China Health Group Ltd
Revenue
|
|||||||||||
|
Cencora Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
673, COR
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
China Health Group Ltd
HKEX:673
|
|||||||||
|
Cencora Inc
NYSE:COR
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
China Health Group Ltd | ||||
|
Cencora Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
673, COR
Performance Gap
673, COR
Performance By Year
673, COR
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|